• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of alteration of tumor microenvironment for drug resistance in lung cancer

Research Project

Project/Area Number 17K16606
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Respiratory surgery
Research InstitutionOsaka University

Principal Investigator

KANZAKI RYU  大阪大学, 医学系研究科, 助教 (10779060)

Project Period (FY) 2017-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords肺癌 / 化学療法 / 腫瘍微小環境 / 癌関連線維芽細胞 / PDGFR-β / 手術 / 癌関連間質細胞 / 外科 / 癌
Outline of Final Research Achievements

Relationships between stromal PDGFR-β expression and survival after operation were analyzed in patients with NSCLC undergoing preoperative chemo- or chemoradiotherapy. Stromal PDGFR-β expression is negatively associated with worse outcomes in these patients. We assessed alterations of tumor microenvironment using cancer-associated fibroblast (CAF) cell line established from resected specimen and mouse model. We found that Gas6 expression by CAFs was upregulated following cisplatin treatment and Gas 6 derived from CAFs promote Axl-expressing lung cancer cells. In clinical samples, stromal Gas6 expression increased after chemotherapy and tumor Axl- and stromal Gas6-positive tumors were significantly worse than for the double negative group. Based on these findings, it is presumed that Gas6 derived from CAFs promotes migration of Axl-expressing lung cancer cells during chemotherapy and is involved in poor clinical outcome.

Academic Significance and Societal Importance of the Research Achievements

肺癌は我が国の死因の首位であり、その治療成績の改善はは喫緊の課題である。肺癌の主たる治療方法の一つに化学療法があるが、抗癌剤を使い続けると癌は薬剤耐性を示し転移能を獲得することが知られており、この現象に癌間質の関与が示唆されている。今回我々は、癌関連線維芽細胞が抗癌剤治療時に癌細胞の悪性化を促す可能性を示唆する機序の一つを解明した。この結果、癌細胞そのものではなく、腫瘍微小環境を構成する細胞が治療のターゲットとなりうる可能性が示唆された。今後腫瘍微小環境をターゲットとした新規治療法の開発が期待される。

Report

(3 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • Research Products

    (9 results)

All 2018 2017

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 1 results) Presentation (6 results) (of which Int'l Joint Research: 3 results)

  • [Journal Article] Stromal PDGFR-β Expression is Associated with Postoperative Survival of Non-Small Cell Lung Cancer Patients Receiving Preoperative Chemo- or Chemoradiotherapy Followed by Surgery2018

    • Author(s)
      Kanzaki Ryu、Ose Naoko、Kawamura Tomohiro、Funaki Soichiro、Shintani Yasushi、Minami Masato、Takakura Nobuyuki、Okumura Meinoshin
    • Journal Title

      World Journal of Surgery

      Volume: 印刷中 Issue: 9 Pages: 2879-2886

    • DOI

      10.1007/s00268-018-4560-7

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.2017

    • Author(s)
      Kanzaki R, Naito H, Kise K, Takara K, Eino D, Minami M, Shintani Y, Funaki S, Kawamura T, Kimura T, Okumura M, Takakura N.
    • Journal Title

      Scientific Reports

      Volume: 7 Issue: 1 Pages: 10613-10613

    • DOI

      10.1038/s41598-017-10873-2

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.2017

    • Author(s)
      Funaki S, Shintani Y, Kawamura T, Kanzaki R, Minami M, Okumura M.
    • Journal Title

      Oncology Report

      Volume: 38 Issue: 4 Pages: 2277-2284

    • DOI

      10.3892/or.2017.5894

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Presentation] cT3-4非小細胞肺癌に対する術前化学放射線療法後肺切除の検討2018

    • Author(s)
      神崎隆、大瀬尚子、川村知裕、舟木壮一郎、新谷康、南正人、奥村明之進
    • Organizer
      第71回日本胸部外科学会定期学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Stromal PDGFR-β expression influences postoperative survival of non-small cell lung cancer patients receiving preoperative chemo- or chemo-radiotherapy2017

    • Author(s)
      Kanzaki R, Naito H, Eino D, Kawamura T, Ose N, Funaki S, Shintani Y, Minami M,Okumura M, Takakura N.
    • Organizer
      18th World Conference on Lung Cancer
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] 非小細胞性肺癌におけるPD-L1発現制御について2017

    • Author(s)
      舟木壮一郎、福井絵里子、川村知裕、神崎 隆、新谷 康、南 正人、奥村明之進
    • Organizer
      第117回日本外科学会定期学術集会
    • Related Report
      2017 Research-status Report
  • [Presentation] 免疫チェックポイント経路PD-1/PD-L1の発現制御による肺癌治療法の確立2017

    • Author(s)
      舟木壮一郎、福井絵里子、川村知裕、神崎 隆、新谷 康、南 正人、奥村明之進
    • Organizer
      第34回日本呼吸器外科学会総会
    • Related Report
      2017 Research-status Report
  • [Presentation] Prognostic impact of Programmed cell death-1 (PD-1) tumor-infiltrating lymphocytes and Programmed cell death-1 -ligand 1 (PD-L1) expression in thymic cancer2017

    • Author(s)
      Funaki S, Shintani Y, Ose N, T. Kawamura T, Kanzaki R, Minami M, Okumura M
    • Organizer
      18th World Conference on Lung Cancer
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Presentation] Effects of pirfenidone targeting EMT and tumor-stroma interaction as novel treatment for non-small cell lung cancer2017

    • Author(s)
      Fujiwara A、Shinatni Y、Funaki S、Kawamura T、Kanzaki R、Fukui E、Minami M、Okumura M
    • Organizer
      Effects of pirfenidone targeting EMT and tumor-stroma interaction as novel treatment for non-small cell lung cancer
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2017-04-28   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi